ProMIS Neurosciences Inc. (PMN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $29.60M
Last updated: Nov 17, 2026 at 11:05 AM ET
ProMIS Neurosciences Inc. (PMN) Stock Forecast
Analysts expect ProMIS Neurosciences (PMN) to earn -$7.36 per share in the fiscal year ending Dec 31, 2026. Of 7 analysts, 7 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$5.48.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 1.86, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 14.3% |
| Buy | 6 | 85.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$7.36
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$5.48
- EPS consensus
- Next report
- Mar 23, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$7.36 | -$7.49 to -$7.23 | 2 |
| Dec 31, 2027 | -$5.48 | -$9.48 to -$3.44 | 8 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.12 | -$1.44 to -$0.90 | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 30 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$8.24.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$7.36 | -$8.17 | -$8.24 | N/A | N/A | N/A |
| Fiscal year ending Dec 31, 2027 | -$5.48 | -$5.48 | -$5.60 | -$5.60 | -$5.27 | N/A |
Frequently Asked Questions About PMN
What is the PMN stock forecast?
Consensus analyst estimates put ProMIS Neurosciences's EPS at -$7.36 for the fiscal year ending Dec 31, 2026. The consensus rating from 7 analysts is Buy.
How do analysts rate PMN stock?
Of 7 analysts covering ProMIS Neurosciences, 1 rates it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from PMN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$7.36, with estimates from -$7.49 to -$7.23 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$5.48, with estimates from -$9.48 to -$3.44 from 8 analysts.
How many analysts cover PMN?
7 analysts rate ProMIS Neurosciences stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PMN pages: Overview, Earnings, Forecast, Competitors